糖共传输体2抑制剂与心脏移植中脏稳定有关
Lisa M Raven1,2,3, Jerry R Greenfield1,2,3, Andrew Jabbour3,4,5
1Department of Diabetes and Endocrinology, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney, Australia.
JHLT open
|April 18, 2025
概括
糖共传输体2抑制剂 (SGLT2i) 可能在患有糖尿病的心脏移植接受者中保持功能. 这项研究发现,在SGLT2i使用者中,估计的膜过率稳定,而非使用者则下降.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏移植 (HTx) 接受者面临2型糖尿病和慢性病 (CKD) 的风险增加.
- 糖尿病和CKD都是HTx患者死亡率增加的独立风险因素.
- 糖共传输体2抑制剂 (SGLT2i) 是已确立的糖尿病,心力衰竭和CKD的治疗方法.
研究的目的:
- 评估SGLT2抑制剂对糖尿病心脏移植接受者的功能的影响.
- 评估SGLT2抑制剂使用与心脏移植后功能变化之间的关联.
主要方法:
- 对104名被诊断患有糖尿病的心脏移植接受者的回顾性分析.
- 在SGLT2抑制剂使用者 (n=23) 和非使用者 (n=81) 之间,移植后3年功能 (估计的球过率) 的比较.
- 对糖尿病类型和基线肌素进行调整的生存分析.
主要成果:
- 用SGLT2抑制剂治疗与稳定的功能相关 (EGFR变化的中位数:0毫升/分钟/1.73米2).
- 没有接触到SGLT2抑制剂的患者显示功能显著下降 (EGFR变化的中位数:-15毫升/分钟/1.73米2;p=0.02).
- 根据SGLT2抑制剂暴露 (调整HR为0.34,p=0.06) 观察到生存没有显著差异.
结论:
- SGLT2 抑制剂可能有助于在患有糖尿病的心脏移植接受者中保持功能.
- 需要进一步的前性研究来证实这些发现并探索结局.
- 调查SGLT2i在HTx接受者的并发症管理中的作用至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
Secondary Active Transport
116.8K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
116.8K
Glucose Transporters
22.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K


